US, EU, and Japan Reach Agreement on Capped Drug Tariffs

The US will honor a 15% tariff cap on drugs from the EU and Japan, promoting smoother trade relations and potentially lowering prices for American consumers. The EU confirmed that US pharma tariffs will remain capped, ensuring stable access to medications. Both the EU and Japan expressed optimism about this development, highlighting the importance of international cooperation in the pharmaceutical sector to address global health challenges.